Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

The Role of Depression, Anxiety, Fatigue, and Fibromyalgia on the Evaluation of the Remission Status in Patients with Rheumatoid Arthritis

Nevsun Inanc, Sibel Yilmaz-Oner, Meryem Can, Tuulikki Sokka and Haner Direskeneli
The Journal of Rheumatology September 2014, 41 (9) 1755-1760; DOI: https://doi.org/10.3899/jrheum.131171
Nevsun Inanc
From the Medical Faculty, and the Department of Rheumatology, Marmara University, Istanbul, Turkey; Jyväskylä Central Hospital, Jyväskylä, Finland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: inanc.nevsun@gmail.com
Sibel Yilmaz-Oner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meryem Can
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tuulikki Sokka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haner Direskeneli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

REFERENCES

  1. 1.↵
    1. Smolen JS,
    2. Aletaha D,
    3. Bijlsma JW,
    4. Breedveld FC,
    5. Boumpas D,
    6. Burmester G,
    7. et al.
    Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:631–7.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Makinen H,
    2. Hannonen P,
    3. Sokka T
    . Definitions of remission for rheumatoid arthritis and review of selected clinical cohorts and randomized clinical trials for the rate of remission. Clin Exp Rheumatol 2006;24:S22–8.
    OpenUrl
  3. 3.↵
    1. Prevoo ML,
    2. van ’t Hof MA,
    3. Kuper HH,
    4. van Leeuwen MA,
    5. van de Putte LB,
    6. van Riel PL
    . Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44–8.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Aletaha D,
    2. Ward MM,
    3. Machold KP,
    4. Nell VP,
    5. Stamm T,
    6. Smolen JS
    . Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum 2005;52:2625–36.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Mäkinen H,
    2. Kautiainen H,
    3. Hannonen P,
    4. Sokka T
    . Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? Ann Rheum Dis 2005;64:1410–3.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Balsa A,
    2. de Miguel E,
    3. Castillo C,
    4. Peiteado D,
    5. Martín-Mola E
    . Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard. Rheumatology 2010;49:683–90.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Felson DT,
    2. Smolen JS,
    3. Wells G,
    4. Zhang B,
    5. van Tuyl LH,
    6. Funovits J,
    7. et al.
    American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis 2011;70:404–13.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Masri KR,
    2. Shaver TS,
    3. Shahouri SH,
    4. Wang S,
    5. Anderson JD,
    6. Busch RE,
    7. et al.
    Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practice. J Rheumatol 2012;39:1139–45.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Studenic P,
    2. Smolen JS,
    3. Aletaha D
    . Near misses of ACR/EULAR criteria for remission: effects of patient global assessment in Boolean and index-based definitions. Ann Rheum Dis 2012;71:1702–5.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Barton JL,
    2. Imboden J,
    3. Graf J,
    4. Glidden D,
    5. Yelin EH,
    6. Schillinger D
    . Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis. Arthritis Care Res 2010;62:857–64.
    OpenUrlCrossRef
  11. 11.↵
    1. Orthendahl M
    . Models based on value and probability in health improve shared decision making. J Eval Clin Pract 2008;14:714–7.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Khan NA,
    2. Spencer HJ,
    3. Abda EA,
    4. Alten R,
    5. Pohl C,
    6. Ancuta C,
    7. et al.
    Patient’s global assessment of disease activity and patient’s assessment of general health for rheumatoid arthritis activity assessment: are they equivalent? Ann Rheum Dis 2012;71:1942–9.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Vermeer M,
    2. Kuper HH,
    3. van der Bijl AE,
    4. Baan H,
    5. Posthumus MD,
    6. Brus HL,
    7. et al.
    The provisional ACR/EULAR definition of remission in RA: a comment on the patient global assessment criterion. Rheumatology 2012;51:1076–80.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Khan NA,
    2. Spencer HJ,
    3. Abda E,
    4. Aggarwal A,
    5. Alten R,
    6. Ancuta C,
    7. et al.
    Determinants of discordance in patients’ and physicians’ rating of rheumatoid arthritis disease activity. Arthritis Care Res 2012;64:206–14.
    OpenUrlCrossRef
  15. 15.↵
    1. Wolfe F,
    2. Smythe HA,
    3. Yunus MB,
    4. Bennett RM,
    5. Bombardier C,
    6. Goldenberg DL,
    7. et al.
    The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160–72.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Wolfe F,
    2. Clauw DJ,
    3. Fitzcharles MA,
    4. Goldenberg DL,
    5. Katz RS,
    6. Mease P,
    7. et al.
    The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010;62:600–10.
    OpenUrlCrossRef
  17. 17.↵
    1. Belza BL
    . Comparison of self-reported fatigue in rheumatoid arthritis and controls. J Rheumatol 1995;22:639–43.
    OpenUrlPubMed
  18. 18.↵
    1. Zigmond AS,
    2. Snaith RP
    . The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Studenic P,
    2. Radner H,
    3. Smolen JS,
    4. Aletaha D
    . Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity. Arthritis Rheum 2012;64:2814–23.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Thiele K,
    2. Huscher D,
    3. Bischoff S,
    4. Späthling-Mestekemper S,
    5. Backhaus M,
    6. Aringer M,
    7. et al.
    Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis. Ann Rheum Dis 2013;72:1194–9.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Katz PP,
    2. Yelin EH
    . Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis. J Rheumatol 1993;20:790–6.
    OpenUrlPubMed
  22. 22.↵
    1. Berkanovic E,
    2. Hurwicz ML,
    3. Lachenbruch PA
    . Concordant and discrepant views of patients’ physical functioning. Arthritis Care Res 1995;8:94–101.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Hider SL,
    2. Tanveer W,
    3. Brownfield A,
    4. Mattey DL,
    5. Packham JC
    . Depression in RA patients treated with anti-TNF is common and under-recognized in the rheumatology clinic. Rheumatology 2009;48:1152–4.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Kekow J,
    2. Moots RJ,
    3. Emery P,
    4. Durez P,
    5. Koenig A,
    6. Singh A,
    7. et al.
    Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial. Ann Rheum Dis 2010;69:222–5.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Wolfe F,
    2. Hawley DJ,
    3. Wilson K
    . The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 1996;23:1407–17.
    OpenUrlPubMed
  26. 26.↵
    1. Pollard LC,
    2. Murray J,
    3. Moody M,
    4. Stewart EJ,
    5. Choy EH
    . A randomised, double-blind, placebo-controlled trial of a recombinant version of human alpha-fetoprotein (MM-093) in patients with active rheumatoid arthritis. Ann Rheum Dis 2007;66:687–9.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Ranzolin A,
    2. Brenol JC,
    3. Bredemeier M,
    4. Guarienti J,
    5. Rizzatti M,
    6. Feldman D,
    7. et al.
    Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis. Arthritis Rheum 2009;61:794–800.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. van Tuyl LH,
    2. Britsemmer K,
    3. Wells GA,
    4. Smolen JS,
    5. Zhang B,
    6. Funovits J,
    7. et al.
    Remission in early rheumatoid arthritis defined by 28 joint counts: limited consequences of residual disease activity in the forefeet on outcome. Ann Rheum Dis 2012;71:33–7.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Bjelland I,
    2. Dahl AA,
    3. Haug TT,
    4. Neckelmann D
    . The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;52:69–77.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 41, Issue 9
1 Sep 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Role of Depression, Anxiety, Fatigue, and Fibromyalgia on the Evaluation of the Remission Status in Patients with Rheumatoid Arthritis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Role of Depression, Anxiety, Fatigue, and Fibromyalgia on the Evaluation of the Remission Status in Patients with Rheumatoid Arthritis
Nevsun Inanc, Sibel Yilmaz-Oner, Meryem Can, Tuulikki Sokka, Haner Direskeneli
The Journal of Rheumatology Sep 2014, 41 (9) 1755-1760; DOI: 10.3899/jrheum.131171

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
The Role of Depression, Anxiety, Fatigue, and Fibromyalgia on the Evaluation of the Remission Status in Patients with Rheumatoid Arthritis
Nevsun Inanc, Sibel Yilmaz-Oner, Meryem Can, Tuulikki Sokka, Haner Direskeneli
The Journal of Rheumatology Sep 2014, 41 (9) 1755-1760; DOI: 10.3899/jrheum.131171
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgment
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters

Keywords

RHEUMATOID ARTHRITIS
REMISSION
DEPRESSION
ANXIETY
FATIGUE
FIBROMYALGIA

Related Articles

Cited By...

More in this TOC Section

  • Clustering Patients With Gout Based on Comorbidities and Biomarkers: A Cross-Sectional Study
  • Pain Mechanisms Associated With Disease Activity in Patients With Rheumatoid Arthritis Treated With Disease-Modifying Antirheumatic Drugs: A Regression Tree Analysis
  • Immunosuppressive Therapies in Ear, Nose, and Throat Involvement in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Results From a Multicenter Retrospective Cohort Study
Show more Article

Similar Articles

Keywords

  • rheumatoid arthritis
  • remission
  • depression
  • anxiety
  • fatigue
  • fibromyalgia

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire